CHGX
0.00%
CHGX
0.00%
ChitogenX Inc.
Status
suspendedT2
Industry
Issued & Outstanding83,129,520
Reserved for Issuance51,869,323
CurrencyCAD
CSE IndexNo
Quote
Last Price—0.00 (0.00%)
Volume0
Change0.00
Bid Size0
Bid Price—
Ask Price—
Ask Size0
Prev Close—
Open—
Day High—
Day Low—
52 Week High—
52 Week Low—
ChitogenX Inc.
Charts by TradingView
Depth Display
CSE
CSE2
Bid Broker | Bid Size | $Bid Price | $Ask Price | Ask Size | Ask Broker |
|---|
Recent Trades
CSE
CSE2
Date/Time | $Price | $Change | Volume | Buyer | Seller |
|---|
About
ChitogenX Inc.
Listing Date
October 10, 2017
Website
ChitogenX Inc. is focused on the following four (4) strategies to create value for its investors:
1. Prioritize activities that will lead to faster commercial status, enabling the Company to leverage on its ability to provide potential licensees with a reliable source of cGMP sterile Chitosan-Based Polymer.
2. Leverage non-dilutive grants secured with Montreal Polytechnique’s partnership to drive proof of concept in multiple indications for the Company’s Chitosan-Based Biopolymer.
3. Leverage its IP portfolio and proof of concept data to attract partnership agreements.
4. Leverage safety data from the completed Rotator Cuff Tear Repair U.S. phase I/II clinical trial to establish and validate the regenerative medicine platform.